Peptide- and Amine-Modified Glucan Particles for the Delivery of Therapeutic siRNA.
about
Targeted Delivery of Glucan Particle Encapsulated Gallium Nanoparticles Inhibits HIV Growth in Human Macrophages.Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance.CRISPR-delivery particles targeting nuclear receptor-interacting protein 1 () in adipose cells to enhance energy expenditure
P2860
Peptide- and Amine-Modified Glucan Particles for the Delivery of Therapeutic siRNA.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 January 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Peptide- and Amine-Modified Glucan Particles for the Delivery of Therapeutic siRNA.
@en
Peptide- and Amine-Modified Glucan Particles for the Delivery of Therapeutic siRNA.
@nl
type
label
Peptide- and Amine-Modified Glucan Particles for the Delivery of Therapeutic siRNA.
@en
Peptide- and Amine-Modified Glucan Particles for the Delivery of Therapeutic siRNA.
@nl
prefLabel
Peptide- and Amine-Modified Glucan Particles for the Delivery of Therapeutic siRNA.
@en
Peptide- and Amine-Modified Glucan Particles for the Delivery of Therapeutic siRNA.
@nl
P2093
P2860
P1476
Peptide- and Amine-Modified Glucan Particles for the Delivery of Therapeutic siRNA.
@en
P2093
Jessica L Cohen
Joseph C Yawe
Michael P Czech
Michaela Tencerova
Myriam Aouadi
Pranitha Vangala
Sarah M Nicoloro
Shinya U Amano
Yuefei Shen
P2860
P304
P356
10.1021/ACS.MOLPHARMACEUT.5B00831
P407
P577
2016-01-27T00:00:00Z